TSM [TAIWAN SEMICONDUCTOR MANUFACTURING CO] 6-K: Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho

[Taiwan Semiconductor Manufacturing Company Ltd. By Lora Ho Senior Vice President & Chief Financial Officer TSMC June 2016 Revenue Report Hsinchu, Taiwan, R.O.C. – July 11, 2016 - TSMC June Revenue Report (Consolidated):]

By | 2016-07-12T03:10:18+00:00 July 11th, 2016|Categories: Chinese Stocks, TSM, Webplus ver|Tags: , , , , , |0 Comments

CHA [CHINA TELECOM] 6-K: (Original Filing)

[Page 1.1 Voluntary announcement in relation to lease of telecommunications towers and related assets from China Tower Corporation Limited, dated July 8, 2016 A-1 • our business and operating strategies and our ability to successfully execute these strategies; • our network expansion and capital expenditure plans; • our operations and business prospects; • the expected benefit of any acquisitions or]

CHA [CHINA TELECOM] 6-K: Page 1.1 Voluntary announcement in relation to lease

[Page 1.1 Voluntary announcement in relation to lease of telecommunications towers and related assets from China Tower Corporation Limited, dated July 8, 2016 A-1 • our business and operating strategies and our ability to successfully execute these strategies; • our network expansion and capital expenditure plans; • our operations and business prospects; • the expected benefit of any acquisitions or]

CHU [CHINA UNICOM (HONG KONG)] 6-K: (Original Filing)

[1 Voluntary Disclosure – Commercial Pricing of the Lease of Telecommunications Towers and Related Assets from China Tower Corporation Limited. • • changes in the PRC telecommunications industry resulting from the issuance of licenses for telecommunications services by the central government of the PRC; • changes in telecommunications and related technologies and applications based on such technologies; • the level]

By | 2016-07-12T03:14:46+00:00 July 11th, 2016|Categories: Chinese Stocks, CHU, SEC Original|Tags: , , , , , |0 Comments

IDI [IDI] 424B3: PROSPECTUS IDI, Inc. 2,869,190 Shares of Common Stock

[PROSPECTUS IDI, Inc. 2,869,190 Shares of Common Stock Risk Factors The common stock offered in this prospectus involves a high degree of risk. See “ No underwriter or other person has been engaged to facilitate the sale of shares of our common stock in this offering. Each selling shareholder may be deemed an underwriter of the shares of our common]

By | 2016-07-09T02:53:15+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: (Original Filing)

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

IDI [IDI] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): July 1, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain]

By | 2016-07-09T02:54:35+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, SEC Original|Tags: , , , , , |0 Comments

OSN [Ossen Innovation] 6-K: Ossen Innovation Enters into Non-Binding Letter of Intent

[Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech's proprietary Dynamic Glucose Monitoring System ("DGMS") provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.] [FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K]

IDI [IDI] 8-K: FORM 8-K CURRENT REPORT Date of Report (Date

[FORM 8-K CURRENT REPORT Date of Report (Date of Earliest Event Reported): July 1, 2016 IDI, Inc. Delaware 333-158336 77-0688094 _____________________ _____________ ______________ of incorporation) Identification No.) 2650 North Military Trail, Suite 300, Boca Raton, Florida 33431 _________________________________ ___________ 561-757-4000 Not Applicable Top of the Form Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain]

By | 2016-07-09T02:55:23+00:00 July 8th, 2016|Categories: Chinese Stocks, IDI, Webplus ver|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] SC 13G: (Original Filing)

[1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Capital Research Global Investors ** 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware 5 SOLE VOTING POWER 3,031,654 6 SHARED VOTING POWER NUMBER OF SHARES NONE BENEFICIALL Y OWNED]

Skip to toolbar